Intracoronary Administration of Levosimendan in Cardiac Surgery Patients

NCT01500785 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Change of schedule

Conditions

Myocardial Stunning

Interventions

DRUG: levosimendan
DRUG: Vitamin B 12

Sponsor

Tampere University Hospital